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Adeno-associated virus (AAV) integrates specifically into a site (AAVS1) on human chromosome 19q13.3–qter. Similarly,
there is accumulating evidence that this site-specific integration occurs by transfection of AAV-based plasmid vectors. In
order to further define the process of plasmid integration events, we constructed some AAV plasmids, introduced them into
HeLa cells by lipofection, and isolated chromosomal integrants. One of such plasmids, pTH-5, contained the rep and
neomycin-resistant (neor) genes flanked by the 59- and 39-inverted terminal repeats of AAV and the hygromycin-resistant
(hygr) gene located in the plasmid backbone. Southern blot analysis revealed that among 36 G418-resistant (G418r) clones
isolated, 22 (61%) showed site-specific integration into AAVS1. Further structural and functional analyses on the expression
of the hygr gene in the site-specific clones and the LacZ gene in clones generated with plasmid pTH-2 indicated that, together
with the AAV sequence, the plasmid backbone was integrated into the AAVS1 site and thus the neor and hygr genes remained
linked at high frequencies in the targeted integrants compared with random integrants. Sequence analysis of integration
junctions between pTH-5 and AAVS1 revealed that the junctions occurred in the p5 promoter region of the plasmid while
mainly in the partial cDNA coding region of the AAVS1 site. We also found that plasmid pTH-1 linearized in the backbone
before lipofection gave a significantly lower frequency of site-specific integration (26%) than the circular form (60%). This
finding may support the involvement of the double-stranded, circular form of infected AAV in the integration process. Our
results may help to understand the process and mechanism of site-specific integration of lipofected AAV plasmid vectors.
© 2000 Academic Press
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aINTRODUCTION
Adeno-associated virus (AAV) is a promising gene
delivery vehicle for gene therapy. AAV is a nonpatho-
genic human parvovirus and its genome consists of
single-stranded linear DNA which is 4.7 kb in length and
accommodates two genes, rep and cap (Muzyczka, 1992;
rivastava et al., 1983). The genes are flanked by 145
ucleotide (nt) inverted terminal repeats (ITRs), which
orm a T-shaped palindromic structure and are required
or DNA replication as the origin, rescue of the provirus,
nd encapsidation of the viral genome (Bohenzky et al.,
988; Lefebvre et al., 1984). The rep open reading frame
s expressed from two promoters positioned at map units
(p5 promoter) and 19 (p19 promoter). The p5 promoter
irects the synthesis of two large rep gene proteins,
ep78 and Rep68, which are essential for viral replica-
ion and trans regulation of gene expression (Beaton et
l., 1989; Berns et al., 1988; Labow et al., 1986; Labow
nd Berns, 1988). The smaller Rep52 and Rep48 proteins
re translated from mRNAs originating from the p19 pro-
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391oter and are essential for virion assembly (Muzyczka,
992). For efficient replication, AAV requires adenovirus
r herpes virus as a helper. In the absence of helper
irus, AAV remains latent within cells by preferentially
ntegrating into a specific site, AAVS1, which is located at
9q13.3–qter in the human chromosome (Kotin et al.,
990, 1991, 1992; Samulski et al., 1991).
The site-specific integration in AAVS1 appears to be
losely associated with DNA replication which requires
he above-noted large Rep78 and Rep68 proteins. These
roteins bind to a specific DNA sequence (the Rep bind-
ng site, RBS) present in the AAV ITRs (Ashktorab and
rivastava, 1989; Im and Muzyczka, 1989), nick the ter-
inal resolution site (TRS) adjacent to the RBS in a
equence- and strand-specific fashion, unwind the ter-
inal repeat with their helicase activity, and initiate DNA
eplication from the nicked site (Im and Muzyczka, 1990).
imilarly, a RBS and a TRS have been identified in the
AVS1 site and Rep78 and Rep68 have been shown to
romote in vitro replication by binding to the RBS and
icking the TRS (Urcelay et al., 1995). Also, Rep68 medi-
ted complex formation between the AAV ITR and the
BS in the AAVS1 in vitro (Weitzman et al., 1994). At
ntegration sites, the head-to-tail organization of the AAV
0042-6822/00 $35.00
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392 TSUNODA ET AL.genome were often found in latently infected cells
(Laughlin et al., 1986; Samulski et al., 1989) and in site-
pecific recombinants obtained in an episomal Epstein–
arr virus (EBV) vector model system (Giraud et al., 1995).
ased on these observations, models for replication-
ediated integration have been proposed (Kotin, 1994;
inden et al., 1996a,b).
For potential use in gene therapy, a major advantage
f AAV vectors is their ability of site-specific integration
nto AAVS1, which could avoid insertional mutations by
andom integration. Recombinant AAV (rAAV) vectors
ave generally been constructed by removing the rep
nd cap genes and placing a transgene of interest be-
ween the AAV ITRs (Samulski et al., 1982). When trans-
uced into human cells, such vectors integrate randomly
nto their chromosomes but not into AAVS1, because of
bsence of the rep gene (Kearns et al., 1996; Rutledge
nd Russell, 1997). Since the AAV genome is small in
ize, the capacity of AAV vectors to package a therapeu-
ic gene is limited (,4.9 kb) (Dong et al., 1996), which
akes it less feasible to construct rAAV which can inte-
rate into AAVS1. On the other hand, transfection with
AV plasmid vectors has no such strict limitations. In
ddition, transfection is, in principle, much safer than
ransduction with viral particles packaged with a recom-
inant viral genome, because plasmid DNA is easily and
ighly purified and low-antigenic compared with viral
articles. During the last decade, there has been a sub-
tantial development of transfection methods; among
hem, lipofection with cationic liposomes currently
eems most promising for nonviral delivery in gene ther-
py (Ledley, 1995; Philip et al., 1994). In recent years,
here have been a few reports that site-specific integra-
ion was observed by transfection of AAV plasmids con-
aining the rep gene (Balague et al., 1997; Shelling and
mith, 1994), or by transfection of AAV plasmids with a
ep expression vector (Surosky et al., 1997) or with the
ep68 protein (Lamartina et al., 1998). However, the pro-
ess of such plasmid integration events has not fully
een explored.
In this study, to define the integration process and
echanism of site-specific integration of AAV plasmid
ectors, we constructed some AAV plasmids, lipofected
hem into HeLa cells, and isolated chromosomal inte-
rants. One of such plasmids, pTH-5, carrying the rep
nd neor genes between the two ITRs and the hygr gene
ownstream of the 39 ITR (within the plasmid backbone)
as been shown to integrate into the AAVS1 site, without
escue by excision of the AAV sequence from the back-
one. We show that integration junctions between pTH-5
nd AAVS1 mainly occurred in the p5 promoter region of
he plasmid while in the partial coding region of the
AVS1. We also show that a linearized AAV plasmid
TH-1 gave a significantly lower frequency of site-spe-
ific integration than the circular one, suggesting the
p
2nvolvement of a double-stranded, circular form of in-
ected AAV in its site-specific integration process.
RESULTS
ite-specific integration of AAV plasmids by
ipofection
To investigate the site specificity of chromosomal in-
egration with AAV plasmid vectors, we constructed
ome plasmids from psub201 (Samulski et al., 1987), as
escribed under Materials and Methods. As shown in
ig. 1, one of such plasmids, pTH-5, contains the rep
ene and the neor gene (in place of the cap gene)
inserted between the 59 and 39 ITRs and the hygr gene
placed in the plasmid backbone downstream of the 39
ITR. We introduced this plasmid into HeLa cells by lipo-
fection with LipofectAMINE, a commercial liposome
product, and then grew them in growth medium contain-
ing active geneticin (G418, 1.0 mg/ml); the resulting col-
onies were isolated and expanded to mass cultures.
Total genomic DNA from each clone was isolated, di-
gested to completion with the restriction endonuclease
EcoRV, and analyzed by Southern blotting with a S1
probe specific for the AAVS1 located in human chromo-
some 19 (Fig. 2). The AAVS1 locus has no restriction site
for EcoRV, while pTH-5 DNA has one site in the herpes
simplex virus thymidine kinase (TK) promoter region (Fig.
1). The control lane (He) of untransfected HeLa cells
showed only a single 6.0-kb band, indicating that AAVS1
exists in the 6.0-kb region (Fig. 2A). The same band was
detected in all G418r clones analyzed, indicating that the
lones carry at least one copy of the undisrupted AAVS1
ocus. In addition, clones 2–6 and 8–10 showed a variety
f “shift bands” which migrated slower than the 6.0-kb
and. Of the 36 clones examined, 28 (78%) exhibited
uch shift bands (Table 1). These extra bands indicate
he occurrence of various rearrangements of the AAVS1
oci (Kotin and Berns, 1989; Kotin et al., 1990, 1992) and
ay also result from site-specific integration of the plas-
id. To examine this, we stripped and rehybridized the
ame membrane to a probe to pTH-5 DNA itself. Many of
hese clones with the shift bands revealed one to three
linked bands,” which could hybridize to the plasmid
robe as well as the S1 probe (Fig. 2B). The appearance
f these linked bands is diagnostic for site-specific inte-
ration of AAV plasmid into the AAVS1 locus (Shelling
nd Smith, 1994; Balague et al., 1997). In this report, we
ave defined clones carrying such linked bands as site-
pecific integrants. As a result, 22 (79%) of the 28 clones
nalyzed showed such linked bands among the shift
ands; the overall frequency of site-specific integration
ith pTH-5 was 61% (Table 1). In other experiments, we
arried out similar experiments with the same pTH-5
lasmid but with hygromycin as a selective drug, isolated
6 hygr clones, and analyzed the clones by Southern
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393SITE-SPECIFIC INTEGRATION OF AAV PLASMID VECTORSblotting. As shown in Table 1, almost identical results
were obtained.
Integration of the backbone structure
When a rAAV plasmid is introduced into human cells
infected with adenovirus as a helper, the AAV genome is
rescued by excision from the plasmid backbone and
replicated (Gottlieb and Muzyczka, 1988; Samulski et al.,
1989; Ward and Berns, 1991). Surosky et al. (1997)
howed that an AAV plasmid carrying the LacZ gene
etween the two ITRs, when cotransfected with a rep
xpression vector, is site-specifically integrated into
AVS1 without excision from the backbone. In contrast,
alague et al. (1997), Pieroni et al. (1998), and Shelling
and Smith (1994) suggested that the AAV genome was
excised from the plasmid backbone, which did not inte-
grate into AAVS1. Therefore, we examined whether the
AAV sequence in pTH-5 was rescued by excision from
the plasmid backbone, or whether the backbone inte-
grated, together with the AAV internal sequence, into the
host chromosome. The genomic DNAs of all G418r
clones used above were digested with the restriction
enzyme HindIII and hybridized to the S1 probe. AAVS1
as no restriction site for the enzyme, while pTH-5 has
FIG. 1. Schematic representation of AAV plasmid vectors used in this
987) as described under Materials and Methods. For simplicity they a
he neomycin-resistant (neor) gene, the hygromycin-resistant (hygr) gen
re shown. The expression of the rep, neor, hygr, and LacZ genes is d
cytomegalovirus enhancer/chicken b-actin) promoters, respectively. P
cap sequence between the HincII sites at nucleotide positions 2398 an
he AAV region in which the internal sequence between the XbaI sites a
hose promoter sites. Horizontal thin and dotted lines represent the Bwo sites, one in the rep gene and the other downstream
of the hygr gene in the plasmid backbone (Fig. 1). As ghown in Fig. 2C, untransfected HeLa cells (lane He)
xhibited a 6.6-kb band; shift bands different in size were
etected in the same positive clones shown in Fig. 2A.
ext, this membrane was stripped and rehybridized with
probe specific for the neor gene (neo probe shown in
ig. 1). The HindIII-digested pTH-5 DNA exhibited a
.2-kb hybridizing band (Fig. 2D), which corresponds to
he neor to hygr gene regions (see Fig. 1). We detected
this diagnostic band in clones 2–6 and 8–10; as a result,
the band was seen in 91% (20/22) of the targeted inte-
grants. In contrast, the same band was found only in 25%
(2/8) of random integrants (data not shown). These re-
sults strongly suggest that the plasmid backbone carry-
ing the hygr gene in pTH-5 occurs in the site-specific
ntegrants and that the rep to neor gene sequences
flanked by the two ITRs were not rescued by excision
from the backbone. Therefore, these results imply that
the entire structure of pTH-5, probably without gross
rearrangements, was integrated into the AAVS1 site.
Functional integrity of a gene in a plasmid backbone
To examine the functional integrity of a gene located at
the backbone sequence in site-specific integrants, we
tested whether the hygr gene located outside of the two
r
The plasmids were constructed from vector psub201 (Samulski et al.,
wn in linear form. Figures are not drawn to scale. The rep (rep) gene,
scherichia coli LacZ gene, and the 59 and 39 ITRs of the AAV genome
y the p5, SV40, TK (herpes simplex virus thymidine kinase), and CAG
pTH-5, pTH-2, and pTH-1 contain the same AAV region in which the
in psub201 is replaced with the neor gene, while pTH3 contains only
ons 191 and 4484 is replaced with the neor gene. Open arrows indicate
t and pEMBL8 sequences, respectively.study.
re sho
e, the E
riven b
lasmids
d 3982ITRs in pTH-5 was actively expressed. The G418 , tar-
eted clones (Table 1) were separately plated and cul-
if
me me
394 TSUNODA ET AL.tured in growth medium containing hygromycin at 0.8
mg/ml, a concentration in which HeLa cells never sur-
vive. Of the 22 clones, 21 were found to grow healthy and,
thus, were clearly hygromycin-resistant, indicating that
FIG. 2. Southern blot analysis of G418-resistant clones derived from
mg) was digested with EcoRV (A, B) or HindIII (C, D), fractionated in a 0
Materials and Methods. (A) Hybridization to the S1 probe specific for A
rehybridized to the pTH-5 DNA probe. Small arrowheads indicate the li
to the S1 probe. A 6.6-kb band corresponds to the AAVS1 site. (D) The sa
HeLa cells and pTH-5, respectively.
T
Site-Specific Integration of AAV Plasmid pTH-5 in H
Drugs
No. of clones
examined
No. of clo
shift b
G418 36 28
Hygromycin 26 17Note. For explanation of shift and linked bands, see the text.the hygr gene is functionally active in almost all of the
ntegrants.
To further confirm the conservation of structure and
unction of a gene placed in a plasmid backbone with a
ells lipofected with AAV plasmid pTH-5. Total genomic DNA (about 12
arose gel and subjected to Southern hybridization as described under
6.0-kb band corresponds to the AAVS1 site. (B) The same membrane
nds that can hybridize to both S1 and pTH-5 probes. (C) Hybridization
mbrane rehybridized to the neo probe (see Fig. 1). He and M represent
lls Selected with Different Drugs after Lipofection
th No. of clones with
linked bands
Site-specific
integration (%)
22 61
14 54HeLa c
.8% ag
AVS1. A
nked baABLE 1
eLa Ce
nes wi
ands
gd
c
q
T
o
p
e
a
t
a
l
G
p
s
A
M
p
t
j
r
s
p
e
r
t
w
r
p
f
C
q
m
(
c
n
S
S
r
a
L
v
i
R
D
d
t
a
i
r
i
f
t
a
e
F
a
t
q
f
a
l
l
395SITE-SPECIFIC INTEGRATION OF AAV PLASMID VECTORSlarge number of colonies, we constructed two AAV plas-
mids carrying the LacZ reporter gene along with the neor
gene. As shown in Fig. 1, pTH-2 contains the rep and
neor genes flanked by the 59 and 39 ITRs and the LacZ
ene inserted downstream of the 39 ITR, while pTH-3
contains only the neor gene within the two ITRs (the rep
sequence was omitted). Both plasmids were lipofected
into HeLa cells and G418r colonies were selected as
escribed under Materials and Methods; the resulting
olonies were stained with X-gal to estimate the fre-
uency of b-galactosidase-positive (b-gal1) colonies.
he frequency observed with pTH-2 was 51% while that
bserved with pTH-3 was 30% (Fig. 3). We isolated,
ropagated, and analyzed some of the clones by South-
rn blotting with the S1 probe. Out of 28 clones gener-
ted with pTH-2, 14 (50%) exhibited shift bands; among
hem all 4 clones analyzed with the neor sequence as a
probe exhibited linked bands. In contrast, none of 10
clones generated with pTH-3 showed any shift band,
indicating failure of site-specific integration (data not
shown). These results indicate that, like pTH-5, pTH-2
preferentially integrated into the AAVS1 locus without
losing the LacZ gene located in the plasmid backbone
and that the reporter gene was conserved more fre-
quently in the site-specific integrants than in the random
integrants. Also, consistent with previous observations
(Lamartina et al., 1998; Surosky et al., 1997), it is evident
that the rep gene product is essential for site-specific
integration.
Sequence analysis of integration junctions
Integration junctions between AAV and AAVS1 are
often observed in the ITR region in latently infected cells
(Kotin and Berns, 1989; Kotin et al., 1992; Samulski et al.,
1991; Yang et al., 1997), and also in the p5 promoter
FIG. 3. Percentage of b-galactosidase-positive (b-gal1) colonies fol-
owing lipofection with AAV plasmid pTH-2 or pTH-3. HeLa cells were
ipofected with either plasmid and selected for G418r colonies as
described under Materials and Methods. The resulting colonies were
stained with X-gal and scored, and the percentage of b-gal1 colonies
was calculated. Error bars represent the SD of three determinations.
Total numbers of colonies assayed are 4642 for pTH-2 and 3050 for
pTH-3.region in an episomal EBV vector model system (Giraud
et al., 1995; Linden et al., 1996a,b). However, sequence
M
tnalysis of junctions between AAV plasmid and AAVS1 is
imited. So we analyzed integration junctions in the
418r, 22 site-specific integrants (Table 1) by PCR am-
lification and sequencing. PCR was performed with two
ets of nested primers specific for the AAV ITR and
AVS1 sequences, as described under Materials and
ethods. Eight of the clones successfully gave amplified
roducts which were then sequenced (Fig. 4A). Impor-
antly, we found that, with respect to the plasmid, all the
unction breakpoints were present in the p5 promoter
egion, especially around the TATA box (TATTTAA) down-
tream of the 59 ITR, except for clone 9 at nucleotide
osition 128 (next to the TRS in the 59 ITR). Therefore,
ven upon lipofection of plasmid vector, the p5 promoter
egion seems to be a hot spot for site-specific integra-
ion. In contrast, no crossover point around the 39 ITR
as observed, although the reason is not known. With
espect to the AAVS1 site, six corresponding break
oints were mapped to the partial coding region except
or clones 10 and 6 occurring near the 39 portion of the
pG island. In Fig. 4B, we aligned the junction se-
uences and found that, at the junctions, there were
icrohomologies of 2–3 nucleotides in 5 of the 8 clones
clones 2–4, 6, and 9) and insertions of 3–4 nts in the 2
lones (clones 3 and 8). Similar structures at recombi-
ation junctions have been reported (Kotin et al., 1992;
amulski et al., 1991).
ite-specific integration with linear pTH-1 plasmid
Upon infection with AAV, single-stranded AAV DNA is
eplicated and becomes double-stranded, linear DNA. In
replication-mediated integration model proposed by
inden et al. (1996a,b), the DNA is assumed to be con-
erted to a circular duplex; the integration reaction is
nitiated by the formation of a complex, mediated by
ep78/68, between the circular duplex DNA and AAVS1
NA, and proceeds through several template switchings
uring synthesis of new DNA strands. If this model is
rue, AAV plasmid would be a better substrate, since it is
lready double-stranded and circular. Conversely, cleav-
ng the plasmid at the backbone sequence would inter-
upt the process of site-specific integration and reduce
ts frequency. However, it is known that linear DNA with
ree ends shows higher frequencies of random integra-
ion than its circular form (Folger et al., 1982; Palmiter et
l., 1984). Keeping this in mind, we examined how lin-
arized AAV plasmid behaved in site-specific integration.
or this experiment, we used a circular pTH-1 plasmid
nd its linear form, which was prepared by digestion with
he restriction enzyme ClaI that cuts the backbone se-
uence once (see Fig. 1). First, we examined the total
requency of chromosomal integration in HeLa cells by
n integration assay as described under Materials and
rethods. The frequency of G418 colonies produced with
he circular plasmid was 6.5 3 1024 on average while
mon to
psub20
396 TSUNODA ET AL.that with the linear one was 4.4 3 1024 (nine determina-
tions), indicating that linearization of the plasmid did not
significantly affect the chromosomal integration. To esti-
mate the frequency of site-specific integration, those
clones were separately isolated, grown to mass cultures,
and analyzed by Southern blotting with the S1 and pTH-1
DNA probes, as described in Fig. 2. Figures 5A and 5B
r
FIG. 4. Sequence analysis of integration junctions between AAV pla
amplified using two sets of nested primers specific for the AAV ITR an
Materials and Methods. (A) Schematic representation of the junction bre
site of human chromosome 19. Only relevant regions are shown. Open
the clone number with the nucleotide position numbered from the le
represents the sequence brought into the AAV genome for cloning of p
upstream of the breakpoint in clone 3-2 and exists at the XbaI site intr
nucleotide sequences at the junctions. Underlined sequences are com
lowercase. Italic sequences show the inserted sequences present inshow shift bands detected with the S1 probe in G418
clones generated (data of linked bands omitted). Itshould be noted that clones generated with the linear-
ized pTH-1 revealed a significantly lower frequency of
both shift and linked bands than clones with the circular
form (Table 2). Of the 43 clones with the circular pTH-1,
29 (67%) showed shift bands and 26 (60%) exhibited
bands linked to the shift bands. This frequency of the
site-specific integration is the same as that observed
TH-5 and AAVS1 in site-specific integrants. The junctions were PCR
S1 sequences and the products were sequenced as described under
ts found in the 59 ITR to the p5 promoter region of pTH-5 and the AAVS1
represent primers for ITR and AAVS1 used. Closed arrows represent
of the 59 ITR in parentheses (Srivastava et al., 1983). The wavy line
psub201 (Samulski et al., 1987); the breakpoint in clone 3-1 (*) is 4 nt
. RBS, Rep binding site; TRS, terminal resolution site. (B) Alignment of
both pTH-5 and AAVS1 sequences. Insertion sequences are shown in
1 but not in the AAV genome (shown above in the wavy line).smid p
d AAV
akpoin
arrows
ft end
lasmid
oducedwith pTH-5 (see Table 1). In contrast, of the 39 clones
generated with the linearized pTH-1, 12 (31%) showed
po
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397SITE-SPECIFIC INTEGRATION OF AAV PLASMID VECTORSshift bands and only 10 (26%) exhibited linked bands
(Table 2). This value may be overestimated, because
some of the targeted clones could come from recircular-
ization of the input linear DNA. As mentioned above,
there was no significant difference in chromosomal in-
tegration frequency between the two forms of trans-
fected pTH-1. Therefore, it is likely that this lowered
frequency of site-specific integration by plasmid linear-
FIG. 5. Southern blot analysis of G418-resistant clones derived from
HeLa cells lipofected with circular or linear AAV plasmid pTH-1. HeLa
cells were lipofected with either form of the plasmid and selected for
G418r colonies, and the resulting colonies were isolated and grown to
mass cultures as described under Materials and Methods. Total
genomic DNA was isolated from each clone, digested with EcoRV, and
processed for Southern blotting as shown in Fig. 2. The S1 probe was
used to detect shift bands. (A) Clones generated with the linear pTH-1.
(B) Clones generated with the circular pTH-1. He represents HeLa cells.
T
Site-Specific Integration in HeLa Cells Lip
Plasmid form
No. of clones
examined
No. of
with shi
Circular 43 2
Linear 39 1Note. For explanation of shift and linked bands, see the text.ization is not due to a increase in random integration but
due to a decrease in the site-specific integration itself.
This may suggest some difference between the mecha-
nisms of AAV site-specific integration and random inte-
gration, as will be discussed below.
DISCUSSION
In this study, we have constructed AAV plasmid vec-
tors and achieved, at high frequencies, their site-specific
integration in HeLa cells by lipofection. The frequency of
the integration with plasmid pTH-5 was 61%, as judged
from the appearance of linked bands hybridizable to both
AAVS1 and plasmid DNA probes by Southern blot anal-
ysis (Fig. 2, Table 1). Similar data were obtained with our
plasmids pTH-2 (Fig. 3) and pTH-1 (Table 2). These re-
sults are in agreement with those indicating that about
40% of transfectants with an AAV plasmid were site-
specific integrants (Shelling and Smith, 1994). For site-
specific integration, the expression of the rep gene is
rerequisite (Lamartina et al., 1998; Surosky et al., 1997).
In the above studies, the rep gene exists at a usual site
of the AAV genome (downstream of the 59 ITR). In con-
trast, there are a few transfection experiments carried
out with AAV plasmids having the rep gene outside the
ITRs (Balague et al., 1997; Lamartina et al., 1998; Pieroni
et al., 1998). Balague et al. (1997) showed a similar
frequency (40%) of site-specific integration with an AAV
plasmid carrying the GFP gene but a lower frequency
with a plasmid carrying the neor gene. Since this and
ther studies have successfully used the neor gene as a
elective marker, the reason for this difference is not
nown. Furthermore, a rep expression vector (Surosky et
l., 1997) or the Rep68 protein (Lamartina et al., 1998)
as introduced along with AAV plasmids. In these cases,
requencies of site-specific integration were low (25% or
ess) compared with plasmids containing the rep gene in
is. In latently infected cells, the integrated AAV provirus
as located at a frequency of 50–70% within the AAVS1
egion (Kotin et al., 1990, 1991, 1992; Samulski et al.,
991). Taking this into consideration, our studies may
mply that AAV plasmids harboring the rep gene between
he two ITRs are suitable for targeting to the AAVS1 site.
When a rAAV plasmid is introduced into human cells
nfected with adenovirus, the AAV genome is rescued by
d with Circular or Linear pTH-1 Plasmid
s
No. of clones with
linked bands
Site-specific
integration (%)
26 60
10 26ABLE 2
ofecte
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ft band
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398 TSUNODA ET AL.excision from the plasmid backbone and replicated (Got-
tlieb and Muzyczka, 1988; Samulski et al., 1989; Ward and
Berns, 1991). Importantly, we find that the hygr gene
ocated outside the ITRs in plasmid pTH-5 was detect-
ble in the AAVS1 in 20 (91%) of the 22 G418r, site-
pecific clones. A similar result was obtained with plas-
id pTH-2 carrying the LacZ gene in the backbone se-
uence (Fig. 3), which was expressed in 50% of the
lones selected in G418. These results indicate that the
xcision of the AAV genome from the plasmid backbone
oes not occur, thus leading to the integration of the
ntire structure of the plasmid into AAVS1 (Fig. 2D). Our
esults are consistent with those described by Surosky et
l. (1997), who have addressed the site-specific integra-
ion, by cotransfection with the rep expression vector, of
he LacZ gene flanked by the AAV ITRs together with the
lasmid backbone. However, these and present data are
n sharp contrast to those suggesting that the backbone
equence outside the ITRs did not integrate into AAVS1
nd, thus, that the AAV genome was rescued by excision
rom its backbone sequence (Balague et al., 1997;
ieroni et al., 1998; Shelling and Smith, 1994). At present,
he reason for the difference is not known.
Sequence analysis of integration junctions between
TH-5 and AAVS1 revealed that seven out of the eight
unctions occurred in the p5 promoter region and, there-
ore, suggests that this region may be a hot spot for
ite-specific integration (Fig. 4A). In viral integrants, junc-
ions have been observed mainly in the ITR region (Kotin
t al., 1992; Samulski et al., 1991; Yang et al., 1997),
hereas junctions were localized in the ITR or near the
5 promoter in the episomal EBV vector model system
Giraud et al., 1995) or in a plasmid integrant (Surosky et
al., 1997). Like the ITR, the p5 promoter contains a Rep
binding sequence to which Rep78 or Rep68 binds and
appears to control p5 transcription (McCarty et al., 1994).
These proteins have been shown to mediate in vitro
complex formation between the ITR and the RBS found in
AAVS1 (Weitzman et al., 1994). Therefore, the above lo-
calization indicates that the RBS present in both the ITR
and the p5 promoter regions acts as an initial site which
allows AAV (or AAV vector) DNA to link to AAVS1 DNA. In
addition, Rep78 and 68 proteins are known to be toxic to
cells and to inhibit their growth (Bantel-Schaal and Stohr,
1992; Yang et al., 1994). Since the rep gene in pTH-5 is
driven by the p5 promoter and the ITR has intrinsic
transcription-promoting activity (Flotte et al., 1993), trun-
cation of these regions caused by integration would
reduce or stop the rep gene expression. It is therefore
possible that clones lacking the gene expression could
outgrow predominantly. With respect to the AAVS1 site,
junction breakpoints in our seven integrants (except one)
were found in the partial coding region (Fig. 4A). This is
consistent with the data observed in latently infected
cells (Samulski et al., 1991), but several breakpoints have
been mapped between the CpG island and the partialcoding region or even outside the latter region (Kotin et
al., 1992; Lamartina et al., 1998). Thus, it seems that
junctions in the AAVS1 may be scattered considerably
throughout the region. However, in the episomal EBV
vector system carrying the cloned AAVS1 segment (Gi-
raud et al., 1995), 80% of the junctions occurred at or near
the RBS in the CpG island. The reason for the difference
is not known, but this may reflect the structural difference
in target AAS1 residing either in the host genome or in
the extrachromosomal vector. We found that seven of the
eight clones analyzed had 2–3 nts of microhomology or
3–4 nts of DNA insertion at the junctions (Fig. 4B), similar
to the observations reported (Kotin et al., 1992; Samulski
et al., 1991). These are characteristic for random integra-
tion events of transfected DNA through nonhomologous
recombination (Roth and Wilson, 1988), indicating that
AAV site-specific and random integrations share some
mechanism.
Our present study indicates that linearization of plas-
mid pTH-1 did not affect chromosomal integration, but
significantly suppressed its site-specific integration (Fig.
5, Table 2). Free DNA ends are well-known to stimulate
random integration of transfected DNA in mammalian
cells (Folger et al., 1982; Palmiter et al., 1984). This has
been explained by the view that random integration oc-
curs through DNA ends (Roth and Wilson, 1988), though
its mechanism has not fully been elucidated. However,
the present result suggests that the site-specific integra-
tion of linear AAV plasmid does not occur at the cleaved
DNA ends but probably at other sites which could be
nicked or cleaved by Rep78/68 protein or some cellular
nucleases prior to or during integration. Linden et al.
(1996a,b) have proposed a replication-mediated integra-
tion model of AAV. This model assumes double-stranded,
circular AAV DNA, “as a starting substrate for integration,”
which could be generated by replication of infected AAV
and subsequent circularization through either end-join-
ing or recombination between the ITRs of both ends; the
integration process is initiated by complex formation
mediated by Rep78/68 protein which binds to the RBS
present in the ITRs of the circular AAV DNA and the
AAVS1, followed by both limited viral and cellular DNA
synthesis accompanying template switching and final
DNA repair. The presence of head-to-tail arrangements
of the AAV provirus found in viral integrants (Laughlin et
al., 1986; McLaughlin et al., 1988; Yang et al., 1997) or in
the episomal EBV vector model system (Giraud et al.,
1995) may be interpreted well by this mechanism. We
find that the entire plasmid structure was integrated into
AAVS1 without rescue by excision from the plasmid
backbone (Fig. 2). Together with this result, our above
finding using linear AAV plasmid also may support the
mechanism, because the linearization of plasmid DNA
should interrupt the continuation of the proposed inte-
gration process coupled tightly with DNA synthesis.
Since AAV integration causes extensive rearrange-
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399SITE-SPECIFIC INTEGRATION OF AAV PLASMID VECTORSments such as deletions, inversions, or translocations of
both viral and cellular DNAs flanking the integration site
(Dyall and Berns, 1998; Giraud et al., 1995; Kotin and
Berns, 1989; Kotin et al., 1990), a foreign gene placed in
AV plasmids would often be disrupted. In this study, the
eor and hygr genes located inside and outside the ITRs,
espectively, remain linked in almost all targeted inte-
rants. Therefore, placing a transgene of interest in the
lasmid backbone may prevent disruption and permit its
table expression. The occurrence of integration junc-
ions in the p5 promoter region allows avoidance of the
xpression of the rep gene after integration. In addition,
lipofection with one of the commercial polycationic lipo-
somes mediates high frequencies of targeted integra-
tion. These data may help us to understand the process
and mechanism of site-specific integration of AAV plas-
mid vectors and to develop improved, nonviral delivery
systems for gene therapy.
MATERIALS AND METHODS
Cell culture
HeLa cells were maintained as monolayer cultures in
ES medium (Nissui, Tokyo) supplemented with 5% heat-
inactivated calf serum (growth medium) at 37°C in a
humidified atmosphere of 5% CO2 in air as described
previously (Fujimaki et al., 1996).
lasmid construction
Standard procedures were followed for plasmid con-
truction, growth, and purification (Sambrook et al.,
989). To construct plasmid pTH-1 containing the neor
gene in place of the viral cap sequence flanked by the
AAV ITRs, both a HincII–HincII fragment and a large
SalI–HincII fragment derived from psub201 (Samulski et
al., 1987) were ligated to the neor gene derived from
cDNA3 (Invitrogen). This neor gene had been amplified
y PCR using Pfu polymerase (Invitrogen) and a set of
rimers: neo-F (59-TGTCAGTTAGGGTGTGGA-39) and
eo-R (59-GTGGAATTGTGAGCGGAT-39). To construct
lasmid pBlue/rep-neo, a 59- to 39-ITR fragment derived
from pTH-1 was subcloned into the SmaI site of pBlue-
script II SK(2) (the XbaI site had been destroyed). To
construct pTH-5, a XbaI–HindIII fragment [TK promoter/
hygr gene/TK poly(A)] of pHm (Fujimaki et al., 1996) was
filled with T4 DNA polymerase (TAKARA, Kyoto) and li-
gated into the EcoRV site in the pBlue/rep-neo plasmid.
To construct pTH-2, plasmid pUCLacZ was first gener-
ated by subcloning a SalI–HindIII fragment of pCAGLacZ
into the SalI–HindIII site in pUC19; next, a SmaI–HindIII
fragment [CAG promoter/LacZ gene/rabbit b-globin
oly(A)] of the pUCLacZ was filled with T4 DNA polymer-
se and ligated into the EcoRV site in pBlue/rep-neo. To
onstruct pTH-3, pBlue/rep-neo was digested with XbaI,
nd a XbaI–XbaI fragment containing the two ITRs wasigated to the neor gene (cleaved with SpeI) derived from
cDNA3. This neor gene had been amplified by PCR
using Pfu polymerase and a set of primers, neo-SpeIF
(59-CAGTACTAGTGTCAGTTAGGGTGTGGA-39) and neo-
SpeIR (59-CAGTACTAGTGGAATTGTGAGCGGAT-39). The
resulting plasmid was digested with EcoRV and ligated
to a blunted SmaI–HindIII fragment derived from pU-
CLacZ.
Transfection
HeLa cells were plated at 1 3 105 per well in 24-well
cluster dishes (Nunc, Tokyo) containing 1 ml of growth
medium. Twenty hours later, a complex made of 0.2 mg of
lasmid pTH-1 or pTH-5 DNA and 1 ml of LipofectAMINE
Gibco BRL) reagent was added to the cell layers as
escribed previously (Fujimaki et al., 1996), and the cells
ere incubated for 3 h. The cells were cultured for an
dditional 20 h in growth medium alone, harvested by
rypsinization, replated in growth medium containing 1.0
g/ml of active geneticin (G418, Sigma) or 0.8 mg/ml of
ctive hygromycin (Sigma), and cultured for 13–15 days
o select for G418r or hygr clones, respectively. One clone
as picked up from each well, grown up to mass cul-
ures in growth medium containing the same amount of
418 or hygromycin.
outhern blot analysis
Total genomic DNA was isolated from each drug-
esistant clone cited above by the method described
Fujimaki et al., 1996). The DNA (approximately 12 mg)
was digested to completion with EcoRV or HindIII ac-
cording to the conditions recommended by the vendor,
fractionated in a 0.8% agarose gel, and blotted onto a
nylon membrane (Hybond N1; Amersham). The mem-
rane was prehybridized for 2 h, and then hybridized for
8 h at 67°C to a [32P]dCTP random primer-labeled probe
specific for AAVS1 (S1 probe), a neo probe, or a whole
pTH-5 DNA probe. The hybridizing band was detected by
autoradiography using a Fujifilm RX-U. Rehybridization of
the same membrane with another probe was done after
the membrane was stripped with NaOH. The S1 probe
was a 1.0-kb fragment derived from HeLa cells by PCR
amplification; the primers used for this probe were 59-
GAACTCTGCCCTCTAACGCTGC-39 and 59-CACCAGATA-
AGGAATCTGCC-39. The neo probe was a 1.6-kb fragment
derived from pTH-5 by PCR amplification; the primers
used for this probe were 59-CAGTACTAGTGTCAGT-
TAGGGTGTGGA-39 and 59-CAGTACTAGTGGAATTGT-
GAGCGGAT-39. These PCR reactions were carried out in
32 cycles, each cycle consisting of 30-s denaturation at
94°C, 30-s annealing at 60°C, and 1-min extension at
72°C, the last extension occurring at 72°C for 7 min. The
PCR products were confirmed by agarose gel electro-
phoresis and purified by phenol extraction and ethanol
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1989).
b-Galactosidase assay
HeLa cells (5 3 105) were lipofected with a complex
made of 0.6 mg of pTH-2 or pTH-3 and 3 ml of Lipo-
fectAMINE as described above. The cells were
trypsinized, replated onto a 100-mm dish in 10 ml of
growth medium with G418 (1.0 mg/ml), and cultured for
13–15 days to select for G418r colonies. The resulting
colonies were stained with X-gal as described previously
(Fujimaki et al., 1996). The number of b-gal1 colonies
ere scored and their percentages were calculated.
ntegration assay
HeLa cells (7 3 105) were lipofected with a complex of
pTH-5 and LipofectAMINE, replated in G418-containing
growth medium, and cultured for 13–15 days to select for
G418r colonies, as described above for a b-galactosi-
dase assay. To estimate cell survival, aliquots of the
lipofected cells were also cultured for 12–14 days in
growth medium. The resulting colonies were fixed with
10% formaldehyde in saline, stained with 0.1% crystal
violet, and scored. The frequency of G418r colonies was
alculated as a function of surviving cells.
unction analysis
Total genomic DNA from each G418r, site-specific
lone was subjected to nested PCR amplification using
wo sets of ITR- and AAVS1-specific primers. The first set
as ITR-1F (59-TCAGTGAGCGAGCGAGCG-39) and
AVS1-1R (59-ATGGCTCCAGGAAATGGGGGTGTGT-39).
he second set was ITR-2F (59-CGCAGAGAGGGAGTG-
CCA-39) and AAVS1-2R (59-CACCAGATAAGGAATCT-
CC-39). The first PCR was performed in 50 ml with about
.5 mg of genomic DNA, 25 pmol each of the first primer
set, 200 mM each of four dNTPs, 1 U Taq polymerase
(TAKARA, Kyoto), and a reaction buffer (10 mM Tris–HCl,
pH 8.3, 50 mM KCl, 1.5 mM MgCl2). PCR was carried out
in 32 cycles, each cycle consisting of 30-s denaturation
at 94°C, 30-s annealing at 62°C, and 1-min extension at
94°C, the last extension occurring at 72°C for 7 min. The
amplified product (0.5 ml) was diluted into a new reaction
ixture containing the second primer set; the parame-
ers were the same as those for the first PCR. Amplified
roducts were purified by fractionation on a 0.8% aga-
ose gel and subcloned into T-vector (Novergen). Cycle
equencing was carried out with SequiTherm EXCEL II
ong-Read DNA sequencing kits-LC (Epicentre Technol-
gies) in a LI-COR automated DNA sequencing machine
sing fluorescent-labeled primers.
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